Indefinite Delivery Contract SPE2DR25D9901

This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Illinois. The contract, valued at $499,999,999, covers a comprehensive range of pharmaceutical products and medical supplies to support the recurring medical needs of military healthcare facilities and veterans' medical centers nationwide.

The IDC enables DLA to issue firm fixed-price delivery orders for branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables across various product categories such as injections, tablets, creams, auto-injectors, and specialty medications. This contract positions DMS Pharmaceutical Group as a crucial supplier in the federal pharmaceutical supply chain, providing direct distribution of prescription drugs and pharmacy services to Department of Defense healthcare sites. The contract has a 30-month base period and three 30-month option periods, aligning with DLA's broader effort to establish Pharmaceutical Prime Vendor Global Program Generation V contracts valued at an estimated $30.3 billion to provide worldwide pharmaceutical support to various DoD customers.